Ontology highlight
ABSTRACT:
SUBMITTER: Chen F
PROVIDER: S-EPMC6129480 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Chen Fangfang F Song Qiaoling Q Yu Qiang Q
American journal of cancer research 20180801 8
R428 (BGB324) is an anti-cancer drug candidate under clinical investigation. It inhibits the receptor tyrosine kinase Axl and induces apoptosis of many types of cancer cells, but the relationship between the two has not been well established. We investigated the molecular mechanisms of the R428-induced apoptosis and found that R428 induced extensive cytoplasmic vacuolization and caspase activation, independent of its inhibitory effects on Axl. Further analyses revealed that R428 blocked lysosoma ...[more]